AD-1058

N/A

Report date: 2025/03/04 16:15:13
NME

Base Information

Drug NameAD-1058
Drug Alias NameAD1058AD-1058
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhongshan Institute for Drug DiscoveryShanghai Institute Of Materia Medica, Chinese Academy Of SciencesShanghai Annova Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Annova Biotechnology Co LtdZhongshan Institute for Drug DiscoveryShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A